Overall case mortality 12%.
Bacteremic pneumococcal community-acquired mortality rate between 19-28%.
A type of bacterial pneumonia that is specifically caused by Streptococcus pneumoniae.
S. pneumoniae is also called pneumococcus.
The most common bacterial pneumonia found in adults.
The estimated number of Americans with pneumococcal pneumonia is 900,000 annually, with almost 400,000 cases hospitalized and fatalities accounting for 5-7% of these cases.
Symptoms can occur suddenly, with a severe chill, with subsequent fever, cough, shortness of breath, rapid breathing, and chest pains.
Patients may have other symptoms like nausea, vomiting, headache, fatigue, and muscle aches could also accompany the original symptoms.
Coughing can be associated with rusty or blood-streaked sputum.
In25% of cases, a parapneumonic effusion may occur.
Chest X-rays will typically show lobar consolidation or patchy infiltrates.
Antibiotic therapy usually helps symptoms between 12 and 36 hours after being taken.
Age and health of the infected patient can contribute to the effectiveness of the antibiotics.
Vaccine for the prevention of pneumococcal pneumonia, is recommended to children under age five as well as adults over the age of 65.
Single agent antibiotic therapy associated with a significantly greater risk of death than dual effective therapy.
- Initial treatment with discordant treatment (inactive in vitro) with monotherapy beta-lactam antibiotic not associated with statistically significant increase in mortality or clinical bacteriological failure compared to monotherapy with concordant beta-lactam antibiotics (active in vitro) for pneumococcal pneumonia.
1954